An Open-Label Pharmacokinetics and Safety Study of Talazoparib
Clinical trial NCT02997163 · COMPLETED
Trial details
- NCT number
- NCT02997163
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-21
- Primary completion
- 2019-01-30
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.